Pharma Equity Group A/S (DK0061155009) — research page
DK · dk-cm-kg/XCSE/DK0061155009 · as of 2026-11-06
Identity and listing
The issuer is Pharma Equity Group A/S, listed on Nasdaq Copenhagen under ticker DK0061155009, ISIN DK0061155009 and LEI 2138008SUI4D917FKN20. Its security type, segment, sector and jurisdiction are not on the record. Its listing status on the record date of 2026-11-06 is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Pharma Equity Group A/S | source · 2026-11-06 |
| exchange | Nasdaq Copenhagen | source · 2026-11-06 |
| ticker | DK0061155009 | source · 2026-11-06 |
| ISIN | DK0061155009 | source · 2026-11-06 |
| LEI | 2138008SUI4D917FKN20 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 18 filings across 16 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 19 days. The latest filing is an Inside information filing dated 2026-09-07, and 60 days separate it from the record date. The exchange median for the same window is 8.0 days of cadence, 25 filings and 4.0 days of latency across 119 issuers. The sector median is not on the record for this market.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 18 | 19 | 60 |
| exchange median: Nasdaq Copenhagen (119 issuers) | 25 | 8 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-09-07 | Inside information | Inside information | Pharma Equity Group A/S - Challenge to Arbitral Award |
| 2026-08-14 | Half Year financial report | Half Year financial report | Pharma Equity Group consolidated Interim Report 1 January - 30 June 2026 |
| 2026-08-14 | Half Year financial report | Half Year financial report | Correction to Consolidated Interim Report 1 January - 30 June 2026 |
| 2026-06-12 | Inside information | Inside information | Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs |
| 2026-05-11 | Inside information | Inside information | Pharma Equity Group's subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record and its location are not on the record. The market's record does not carry auditor changes.
Events and halts
The record carries no listing, delisting, name change, domicile change or segment move lines, because no lifecycle type map exists for this register. The halt flag is listed, not halted.
Orderability
The outcome is not determinable for this issuer under rule version acm-68000/dk/mifid-ii-product-governance/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.
rule acm-68000/dk/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 2 research houses: HC Andersen Capital, Denmark, and HC Andersen Capital.
| research house | analyst | source · read date |
|---|---|---|
| HC Andersen Capital, Denmark | issuer page · 2026-11-12 | |
| HC Andersen Capital | Claus | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.dk-cm-kg.ai/events/XCSE/DK0061155009 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterCPH|FirstNorthInformationCPH (the halt flag)
- 10.5
- https://dk.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://pharmaequitygroup.com/investors/ (coverage)
- 10.7
- https://mcp.dk-cm-kg.ai/record/XCSE/DK0061155009 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"DK0061155009"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f9223d2309e0df58.